RECOVERY INC A 424B Filings

MSP Recovery, Inc. (MSPR) filed a prospectus supplement registering for resale up to 285,715 shares of Class A Common Stock that may be issued to YA II PN, Ltd. (Yorkville) under a $250 million Standby Equity Purchase Agreement. Shares sold to Yorkville are priced at 97–98% of VWAP, subject to a $0.50 floor and a 9.99% beneficial ownership cap. The prior 19.99% exchange cap has been lifted by stockholder approval.

The company has issued multiple Convertible Notes to Yorkville totaling $15.75 million in principal, generally bearing 5.0% interest (up to 18.0% on default) and maturing on November 30, 2026, with conversion at the lower of fixed prices per note or 95% of the lowest seven-day VWAP, but not below the $0.50 floor. MSP Recovery effected a 1‑for‑7 reverse stock split on September 1, 2025 and its securities now trade only on OTC venues with no active public trading market.

The attached Form 8‑K describes very small, one-time liquidity measures: Hazel Partners Holdings LLC provided two discretionary $0.03 million advances each (total $0.06 million) under a working capital credit facility, and VRM MSP Recovery Partners, LLC provided two $0.03 million recovery‑proceeds advances (total $0.06 million). The company states the facility offers no committed liquidity, no remaining availability beyond these amounts, and “no reasonable basis to expect” further advances.

MSP Recovery, Inc. (MSPR) filed a prospectus supplement registering for resale up to 32,220 shares of Class A common stock held by selling securityholders, including 15,239 shares issuable upon exercise of a CPIA Warrant at $0.4375 per share, from which the company would receive only nominal proceeds if exercised.

The company’s common stock and warrants are quoted on the OTC Markets Group’s Expert Market and lack an active public trading market, so current closing prices are not publicly available. A 1-for-7 reverse stock split of common stock became effective at 11:59 PM EDT on September 1, 2025, and share data in this supplement reflect that adjustment.

MSP Recovery also reports new short-term financing: Hazel Partners Holdings LLC provided two discretionary advances of $0.03 million each under a working capital facility, and VRM MSP Recovery Partners, LLC provided two one-time advances of $0.03 million each, all for operating expenses. These are standalone accommodations; the company states it has no rights to, and no reasonable basis to expect, any further advances under the Hazel facility and that the agreements do not provide access to ongoing liquidity.

MSP Recovery, Inc. (MSPR) filed a prospectus supplement covering the potential resale by selling securityholders of up to 56,896 shares of Class A common stock. This includes 28,572 shares issuable upon exercise of low-priced VRM warrants, 2,858 issued shares and 14,286 warrant shares for VRP, and 11,180 shares issued to Palantir for products and services. The company would receive only nominal proceeds from warrant exercises at an exercise price of $0.0175 per share, and receives no proceeds from resale transactions.

The filing also attaches a Form 8-K describing new short-term funding arrangements. Hazel Partners Holdings LLC provided two discretionary advances of $0.03 million each under an existing working capital credit facility, and VRM MSP Recovery Partners, LLC provided two one-time advances of recovery proceeds of $0.03 million each, all primarily for operating expenses. The company states that these are standalone accommodations, the facility remains fully discretionary, and there is currently no additional committed or expected funding available under the facility or from VRM.

MSP Recovery, Inc. updates its resale registration, allowing selling securityholders to offer up to 909,982 shares of Class A common stock and up to 755,200,000 warrants, and registering up to 236,019 shares issuable upon exercise of warrants. The common stock and warrants trade only via unsolicited quotations on the OTC Expert Market, and there is no active public trading market. All share data reflect a 1-for-7 reverse stock split effective September 1, 2025.

The company also discloses very small, highly discretionary liquidity infusions. Hazel Partners Holdings LLC advanced $0.05 million and $0.06 million under the working capital credit facility’s Operational Collection Floor, characterized as one-time accommodations that do not reinstate availability or create any funding commitment. VRM MSP Recovery Partners, LLC separately provided one-time advances of $0.05 million each, limited to payroll and IT expenses. MSP Recovery states it has no rights to, and no reasonable basis to expect, further advances under these arrangements and cautions that these amounts do not indicate broader liquidity or ability to meet ongoing obligations.

MSP Recovery, Inc. updates its prospectus to cover the resale by Yorkville of up to 285,715 shares of Class A common stock issuable under a $250 million Standby Equity Purchase Agreement. These are being registered for Yorkville’s account; the company will not receive proceeds from Yorkville’s resales.

The Yorkville facility includes convertible notes with fixed conversion prices for specific notes and a variable conversion feature tied to 95% of the lowest VWAP, subject to a $0.50 floor price and a 9.99% Ownership Limitation. Prior stockholder approval effectively lifted a 158,295‑share, 19.99% Exchange Cap, allowing further issuances under the SEPA and notes.

The attached current report also discloses very small, highly discretionary liquidity infusions: Hazel Partners Holdings LLC provided one‑time working‑capital advances of $0.05 million and $0.06 million under its credit facility, and VRM MSP Recovery Partners, LLC advanced $0.05 million twice for payroll and IT expenses. The company notes these do not restore committed availability or create any right or expectation of future funding. The stock now trades on OTC venues, including the Expert Market, and lacks an active public trading market.

MSP Recovery, Inc. updates its resale registration to cover up to 32,220 shares of Class A common stock, including up to 15,239 shares issuable upon exercise of the CPIA Warrant at an exercise price of $0.4375 per share. Any warrant exercise would generate only nominal proceeds for the company. The securities are eligible for unsolicited quotations on the OTC Expert Market, and there is no active public trading market; current closing prices are not publicly available. Share data reflects a 1-for-7 reverse stock split effective September 1, 2025.

Through attached disclosures, the company reports small, one-time funding advances to support operating expenses and payroll. Hazel Partners Holdings LLC provided discretionary advances of $0.05 million and $0.06 million under a working capital credit facility that offers no committed liquidity and imposes no obligation to fund further amounts. VRM MSP Recovery Partners, LLC agreed to additional one-time advances of $0.05 million each, earmarked for payroll and IT costs. MSP Recovery states it has no rights to, and no reasonable basis to expect, further advances under these arrangements, and cautions that these advances should not be viewed as evidence of future funding capacity or its ability to meet ongoing obligations.

MSP Recovery, Inc. is updating a resale registration covering up to 56,896 shares of Class A common stock to reflect a new current report. The shares may be sold from time to time by selling securityholders and include 28,572 shares issuable on exercise of VRM warrants, 2,858 shares issued to VRP, 14,286 shares issuable on a VRP warrant, and 11,180 shares issued to Palantir. The VRM and VRP warrants have a low exercise price of $0.0175 per share, so any proceeds to the company from exercises would be nominal. The company’s common stock and warrants trade only via unsolicited quotations on the OTC Expert Market and currently lack an active public trading market. A 1-for-7 reverse stock split became effective on September 1, 2025.

MSP Recovery also discloses incremental short-term funding arrangements. Hazel Partners Holdings LLC provided one-time advances of $0.05 million and $0.06 million under a discretionary working capital credit facility, increasing the Operational Collection Floor but without creating any ongoing borrowing capacity or funding commitment. VRM MSP Recovery Partners, LLC made two one-time advances of recovery proceeds of $0.05 million each to support payroll and IT expenses. The company states that these are standalone accommodations, do not reinstate availability under the facility, and that it has no rights to, and no reasonable basis to expect, further advances.

MSP Recovery, Inc. files a prospectus supplement updating its resale registration and attaching a recent current report. The supplement covers the potential resale by selling securityholders of up to 909,982 shares of Class A common stock and up to 755,200,000 warrants, plus the company’s potential issuance of up to 236,019 shares upon warrant exercise. A 1-for-7 reverse stock split became effective at 11:59 PM EDT on September 1, 2025, and share figures reflect this adjustment.

The attached current report describes two discretionary advances under the company’s working capital credit facility with Hazel Partners Holdings LLC: $0.07 million funded on July 20, 2026, and $0.05 million funded on July 29, 2026, for operating expenses. These are one-time accommodations that do not restore or expand ongoing borrowing capacity. The company states that beyond these advances it has no rights to, and no reasonable basis to expect, further funding under the facility and cautions that the facility does not provide committed liquidity.

MSP Recovery, Inc. filed a prospectus supplement registering up to 285,715 shares of Class A common stock for resale by YA II PN, Ltd. (Yorkville) under an existing Standby Equity Purchase Agreement (Yorkville SEPA). The SEPA permits the company, at its election, to sell up to $250 million of Class A shares to Yorkville, subject to a 9.99% ownership cap and a minimum conversion and sale price floor of $0.50 per share.

The filing describes multiple convertible notes issued to Yorkville totaling agreed principal of $15.75 million plus additional advances, bearing 5.0% interest (rising to 18.0% upon an event of default) and convertible at fixed prices for each note or at 95% of the lowest VWAP over a short lookback period, but never below the floor price. Ongoing amendments have repeatedly reduced the floor price and extended note maturities.

The attached Form 8‑K discloses that subsidiary borrowers obtained two discretionary working‑capital advances of $0.07 million and $0.05 million from Hazel Partners Holdings LLC under an existing facility to fund operating expenses. The company states these are one‑time accommodations, do not restore ongoing availability, and that it has no rights to and no reasonable basis to expect further funding under that facility. The stock now trades on OTCQB and is only eligible for unsolicited quotations on the Expert Market, with no active public trading market.

MSP Recovery, Inc. is updating its resale registration to cover up to 32,220 shares of Class A common stock held by selling securityholders, including 15,239 shares issuable upon exercise of the CPIA Warrant at an exercise price of $0.4375 per share. Any exercise of this warrant would provide only nominal cash proceeds to the company. A 1-for-7 reverse stock split of the common stock became effective on September 1, 2025, and the share figures reflect this adjustment. The common stock and warrants are quoted on the OTC Markets Group’s Expert Market and do not have an active public trading market.

Through subsidiaries, the company entered into two letter agreements with Hazel Partners Holdings LLC under its working capital credit facility, providing $0.07 million and $0.05 million of discretionary advances primarily for operating expenses. These one-time advances increased the Operational Collection Floor beyond the previously disclosed $6.0 million of aggregate advances but do not reinstate or reopen ongoing availability. The company states it has no rights to, and no reasonable basis to expect, further advances and that these arrangements do not provide access to recurring liquidity.

MSP Recovery, Inc. updates its resale registration to cover up to 56,896 shares of Class A common stock for selling securityholders, including shares and low-priced warrants held by Virage-affiliated funds and 11,180 shares issued to Palantir Technologies, Inc. as consideration for products and services. The VRM and VRP warrants carry an exercise price of $0.0175 per share, so any proceeds to the company from exercise would be nominal. The company’s common stock and warrants trade only via unsolicited quotations on the OTC Expert Market and lack an active public market. A 1-for-7 reverse stock split became effective on September 1, 2025, and share data have been adjusted.

Through subsidiaries, MSP Recovery also obtained two discretionary advances from Hazel Partners Holdings LLC under its working capital credit facility: $0.07 million on July 20, 2026 and $0.05 million on July 29, 2026, primarily for operating expenses. These standalone accommodations increase the Operational Collection Floor beyond approximately $6.0 million of prior advances but do not reinstate or reopen ongoing availability, create any future funding commitment, or provide recurring liquidity, and the company states it has no rights to, and no reasonable basis to expect, further advances.

MSP Recovery, Inc. filed a prospectus supplement covering the resale by selling securityholders of up to 56,896 shares of Class A Common Stock. This includes 28,572 shares issuable upon exercise of VRM warrants, 2,858 shares issued to VRP and 14,286 shares issuable upon exercise of a VRP warrant, and 11,180 shares issued to Palantir as consideration for products and services. The VRM and VRP warrants carry a low $0.0175 per share exercise price, so any exercise would generate only nominal proceeds for the company. A 1-for-7 reverse stock split became effective on September 1, 2025, and all share data here reflects that split.

MSP Recovery also entered into a July 8, 2026 letter agreement with VRM MSP Recovery Partners, LLC, under which VRM agreed to provide a one-time $0.3 million advance to support operating expenses under a previously approved budget. VRM emphasized that this is a one-time accommodation, does not obligate it to provide future funding, and does not change the priority of its existing liens or constitute a novation of existing obligations.

MSP Recovery, Inc. registers up to 285,715 shares of Class A common stock for resale by YA II PN, Ltd. (Yorkville) under a Standby Equity Purchase Agreement (Yorkville SEPA). These shares may be issued at the Company’s election, with no proceeds to the Company from Yorkville’s resales.

The Yorkville SEPA permits issuances of up to $250 million of Class A common stock, subject to a 9.99% beneficial ownership cap and a pricing formula based on Nasdaq/OTCQB VWAPs and a $0.50 floor price. Yorkville has also advanced convertible promissory notes totaling $15.75 million plus additional funding commitments, bearing 5.0% interest and generally maturing on November 30, 2026, with conversion at the lower of fixed prices or 95% of recent VWAP, but not below the floor.

The Company’s stock was delisted from Nasdaq and now trades on OTCQB, which constituted an event of default under the notes; Yorkville agreed to extend the related cure period while the stock trades on OTCQB. Separately, VRM MSP Recovery Partners, LLC agreed to a one-time $0.3 million advance to support operating expenses and entered into related amendments to the Master Transaction Agreement and Security Agreement, creating an additional direct financial obligation.

MSP Recovery, Inc. filed a prospectus supplement covering the resale by selling securityholders of up to 32,220 shares of Class A Common Stock, including 15,239 shares issuable upon exercise of the CPIA Warrant held by Brickell Key Investments LP. The CPIA Warrant has an exercise price of $0.4375 per share, and the company states it would receive only nominal proceeds if it is exercised. Class A common stock, Public Warrants, and New Warrants trade on OTC Markets under the symbols MSPR, MSPRZ, and MSPRW, with closing prices on July 10, 2026 of $0.0185, $0.0058, and $0.0001, respectively. Effective September 1, 2025, a 1‑for‑7 reverse stock split was implemented, and the share data reflect this split.

Separately, MSP Recovery entered into a July 2026 VRM Letter Agreement under which VRM MSP Recovery Partners, LLC agreed to provide a one‑time $0.3 million advance to support operating expenses under a VRM‑approved budget. The advance is described as a one‑time accommodation and does not obligate VRM or its affiliates to provide additional funding. The agreement also includes amendments to the existing Master Transaction Agreement and Amended and Restated Security Agreement while preserving VRM’s existing lien priority, and it is characterized as creating a direct financial obligation.

MSP Recovery, Inc. filed a prospectus supplement updating an existing resale registration tied to a Current Report on Form 8-K dated July 8, 2026. The filing covers the resale of up to 909,982 shares of Class A common stock and up to 755,200,000 warrants to purchase Class A common stock, plus the issuance of up to 236,019 shares issuable upon warrant exercise.

The company notes a previously implemented 1-for-7 reverse stock split effective September 1, 2025, and provides recent OTC trading prices for its common stock and warrants. The attached 8-K describes a $0.3 million one-time advance from VRM MSP Recovery Partners, LLC to support operating expenses under a VRM-approved budget, with VRM reserving all rights and no obligation for future funding.

MSP Recovery, Inc. files a prospectus supplement to register the resale of 32,220 shares of Class A Common Stock.

The registration includes up to 15,239 shares issuable upon exercise of the CPIA Warrant at an exercise price of $0.4375 per share, which would produce only nominal proceeds to the company if exercised. The company effected a 1-for-7 reverse stock split effective September 1, 2025. Market quotes on July 7, 2026 showed the common stock at $0.0198, Public Warrants at $0.0045, and New Warrants at $0.0002. The company disclosed it remains delinquent in certain SEC reports and that OTC Markets will move its securities to the Expert Market effective on or around July 17, 2026.

MSP Recovery, Inc. files a prospectus supplement and Form 8-K registering 285,715 shares of Class A Common Stock for resale by Yorkville under a standby equity purchase agreement.

The filing describes the Yorkville SEPA (up to $250 million capacity), related Convertible Notes totaling $15.75 million originally, multiple subsequent advances, conversion mechanics with specified conversion prices and a 9.99% Ownership Limitation. The company notes its Class A common stock moved from Nasdaq to the OTCQB and that trading will be designated on the OTC Markets "Expert Market" effective July 17, 2026.

MSP Recovery, Inc. registered 56,896 shares of Class A Common Stock for resale by selling securityholders under Prospectus Supplement No. 53, including shares issuable on specified warrants and shares issued as consideration.

The supplement attaches a Form 8-K disclosing the Company is delinquent in its SEC filings and was notified by OTC Markets that its publicly traded securities will be moved to the Expert Market, effective on or around July 17, 2026, because the Company does not expect to regain current reporting status by the end of the grace period. The prospectus notes a 1-for-7 reverse stock split effective September 1, 2025, and states exercise prices on certain warrants are nominal ($0.0175), so proceeds on any exercises would be nominal.

MSP Recovery, Inc. files a prospectus supplement registering up to 909,982 shares of Class A Common Stock and up to 755,200,000 warrants, and noting up to 236,019 shares issuable upon exercise of warrants.

The supplement incorporates a Form 8-K disclosing the Company’s move to the OTC Markets Expert Market effective on or around July 17, 2026 due to delinquent SEC filings and confirms a 1-for-7 reverse stock split effective September 1, 2025.

MSP Recovery, Inc. supplements its August 5, 2022 prospectus to register resale and warrant-related securities, listing up to 909,982 shares of Class A Common Stock, up to 755,200,000 warrants, and up to 236,019 shares issuable upon exercise of warrants.

The company also filed a Current Report disclosing a one-time Hazel Letter Agreement advance of $0.2 million funded June 26, 2026, under the discretionary Operational Collection Floor of its Working Capital Credit Facility. The prospectus notes a prior 1-for-7 reverse stock split effective September 1, 2025, and provides June 29, 2026 closing market prices for common stock and warrants.

MSP Recovery, Inc. files a prospectus supplement registering 285,715 shares of Class A Common Stock for offer and sale by the selling securityholder under its Form S-1 registration.

The supplement updates the prospectus with a Current Report on June 30, 2026 and describes the Yorkville SEPA, under which the company may issue and sell shares to YA II PN, Ltd. up to an aggregate contractual capacity of $250,000,000 (subject to ownership and exchange caps). The Yorkville arrangements include convertible notes and multiple amendments that set conversion mechanics, pricing floors, and historical Floor Price adjustments. The supplement notes that sales by Yorkville are resale transactions for which the company will not receive proceeds when Yorkville sells its shares; proceeds treatment for company-issued sales under the SEPA is described separately in the prospectus.

MSP Recovery, Inc. filed a Prospectus Supplement No. 63 updating its resale prospectus to cover the offer and sale of up to 32,220 shares of Class A Common Stock, including up to 15,239 shares issuable upon exercise of the CPIA Warrant at an exercise price of $0.4375 per share. The supplement attaches a Form 8-K describing a one-time $0.2 million advance from Hazel Partners Holdings, LLC under the Company’s discretionary Working Capital Credit Facility. The supplement notes closing market prices as of June 29, 2026 and that share counts reflect a 1-for-7 reverse stock split effective September 1, 2025.

MSP Recovery, Inc. amends its October 4, 2024 prospectus to register for resale 56,896 shares of Class A Common Stock. The supplement incorporates a Current Report on Form 8-K disclosing a one-time $0.2 million advance from Hazel Partners under the Company’s working capital facility and other selling‑holder details.

The registered shares include warrants issuable to Virage affiliates and shares issued to Palantir; the VRM and VRP warrants have a $0.0175 per‑share exercise price. Share and per‑share amounts reflect a 1-for-7 reverse stock split effective September 1, 2025.

MSP Recovery, Inc. amends its prospectus to register up to 909,982 shares of Class A Common Stock for resale by selling securityholders and to register up to 755,200,000 warrants and up to 236,019 shares issuable upon exercise of warrants.

The supplement gives effect to a 1-for-7 reverse stock split effective September 1, 2025 and discloses market closing prices on June 17, 2026. Separately, the company received a $0.1 million one‑time discretionary advance from Hazel Partners Holdings LLC under its working capital credit facility; aggregate prior advances under that discretionary mechanism had reached $6.0 million.

MSP Recovery, Inc. filed Prospectus Supplement No. 64 registering 285,715 shares of Class A Common Stock for resale by YA II PN, Ltd. (Yorkville) under a Standby Equity Purchase Agreement (Yorkville SEPA). The SEPA contemplates up to $250 million of purchases subject to a 9.99% Ownership Limitation and earlier Exchange Cap mechanics. The supplement updates prior terms and attaches a Form 8-K describing a separate $0.1 million discretionary advance from Hazel Partners under the working capital facility. The prospectus states the Company will not receive proceeds from resales by Yorkville, while sales the Company elects to make to Yorkville under the SEPA could generate proceeds to the Company.

MSP Recovery, Inc. files a prospectus supplement registering 32,220 shares of Class A common stock for resale by selling securityholders, including up to 15,239 shares issuable upon exercise of a warrant (the CPIA Warrant). The CPIA Warrant exercise price is $0.4375 per share, so exercise would produce only nominal proceeds to the company.

The supplement attaches a Form 8-K disclosing a one-time $0.1 million discretionary advance from Hazel Partners Holdings LLC under the company’s working capital credit facility and notes that the facility remains discretionary with no committed availability. The company effected a 1-for-7 reverse stock split effective September 1, 2025.

MSP Recovery, Inc. files Prospectus Supplement No. 51 to register 56,896 shares of Class A Common Stock for resale by selling securityholders, including warrants exercisable into shares and shares issued for services. The supplement reflects a 1-for-7 reverse stock split effective September 1, 2025.

The prospectus lists (i) up to 28,572 shares issuable on exercise of VRM Warrants, (ii) 2,858 shares issued to VRP plus up to 14,286 shares issuable on a VRP Warrant, and (iii) 11,180 shares issued to Palantir. Exercise price for VRM and VRP warrants is $0.0175 per share. The supplement attaches the Company’s Form 8-K disclosing a one-time $0.1 million advance from Hazel under a discretionary working capital mechanism; prior advances under that mechanism totaled approximately $6.0 million.

MSP Recovery, Inc. files a prospectus supplement registering up to 909,982 shares of Class A Common Stock, up to 755,200,000 warrants, and up to 236,019 shares underlying warrants, adjusted for a 1-for-7 reverse stock split.

The supplement attaches a Form 8-K describing short-term funding: a one-time $0.1 million advance from Hazel Partners Holdings, LLC and two one-time accommodations from VRM MSP Recovery Partners, LLC totaling $0.12 million (a $0.06 million advance plus retention of $0.06 million). The company cautions these are standalone, discretionary advances and do not reopen committed availability under its working capital credit facility.

MSP Recovery, Inc. registers 285,715 shares of Class A Common Stock for resale by a selling securityholder under a prospectus supplement dated June 4, 2026. The shares relate to issuances tied to the Yorkville SEPA, under which the Company may issue up to $250 million of Class A Common Stock to YA II PN, Ltd., subject to an Ownership Limitation (9.99%) and the previously applicable Exchange Cap.

The prospectus states that the Company will not receive proceeds from sales by Yorkville under this prospectus, although the Company may receive proceeds if it elects to sell shares to Yorkville under the Yorkville SEPA. The Yorkville arrangement also includes Convertible Notes with an aggregate principal of $15.75 million and conversion mechanics tied to specified fixed prices and a VWAP floor of $0.50. The filing discloses multiple Floor Price reductions culminating in a $0.50 Floor Price, the Company’s Nasdaq delisting and transfer to the OTCQB, and reported closing Common Stock price of $0.0269 on June 3, 2026.

MSP Recovery, Inc. registers 32,220 shares of Class A Common Stock for resale by selling securityholders, including up to 15,239 shares issuable upon exercise of the CPIA Warrant.

The prospectus supplement attaches a Form 8-K that discloses short-term funding arrangements: a $0.1 million one-time advance from Hazel Partners (made May 29, 2026) and two VRM arrangements permitting a $0.06 million advance and a $0.06 million retention of recovery proceeds. The CPIA Warrant exercise price is $0.4375 per share and would yield only nominal proceeds to the company if exercised.

MSP Recovery, Inc. is amending its October 4, 2024 prospectus to register up to 56,896 shares of Class A Common Stock for resale by selling securityholders. The registered shares include 28,572 shares issuable upon exercise of VRM Warrants, 2,858 shares issued to VRP plus 14,286 issuable under a VRP Warrant, and 11,180 shares issued as consideration to Palantir Technologies, Inc.

The supplement attaches a Form 8-K reporting May 29, 2026 letter agreements: a Hazel one-time advance of $0.1 million, VRM one-time advance of $0.06 million and a permitted retention of $0.06 million of recovery proceeds. The supplement notes a 1-for-7 reverse split effective September 1, 2025; share and per-share figures are adjusted accordingly.

MSP Recovery, Inc. files a prospectus supplement registering 56,896 shares of Class A Common Stock for resale by selling securityholders. The registration includes 28,572 shares issuable upon exercise of VRM Warrants, 2,858 shares issued and 14,286 issuable upon a VRP Warrant, and 11,180 shares issued to Palantir.

The supplement attaches a Form 8-K disclosing one-time advances of $94,000 each from Hazel Partners and VRM on May 15, 2026, and notes the Company’s downgrade from the OTCQB to the OTC Pink market for failure to timely file its 2025 Form 10-K.

MSP Recovery, Inc. files a prospectus supplement registering 285,715 shares of Class A Common Stock for resale by YA II PN, Ltd. (Yorkville) under a Standby Equity Purchase Agreement (the Yorkville SEPA). The Yorkville SEPA contemplates purchases of up to $250 million of common stock, subject to a 9.99% Ownership Limitation and formerly an Exchange Cap that was lifted effective January 8, 2025. The supplement describes Convertible Notes issued to Yorkville (initial aggregate principal $15.75 million plus subsequent advances and Supplemental Agreements), conversion mechanics including specified per-note conversion prices and a $0.50 Floor Price, and a series of Floor Price reductions down to $0.50. The prospectus states the Company expects no proceeds from Yorkville’s resale activity; proceeds may arise if the Company elects to sell shares to Yorkville under the SEPA. The filing also attaches a Form 8-K disclosing one-time advances of $0.1 million each from Hazel and VRM, and notices that Class A common stock was downgraded from the OTCQB to the OTC Pink market effective May 20, 2026.

MSP Recovery, Inc. registers the resale of up to 32,220 shares of Class A Common Stock under Prospectus Supplement No. 60, including up to 15,239 shares issuable upon exercise of a warrant (the CPIA Warrant).

The supplement attaches the Company’s Form 8-K reporting two one-time advances of approximately $94,000 and $0.1 million, and notice from OTC Markets that the Company will be downgraded from the OTCQB Venture Market to the OTC Pink market effective at the open of trading on May 20, 2026.

MSP Recovery, Inc. files a Prospectus Supplement No. 67 and an attached Current Report on Form 8-K describing a resale registration and related financing updates. The supplement registers up to 909,982 shares of Class A Common Stock, up to 755,200,000 warrants, and up to 236,019 shares issuable upon exercise of warrants.

The Form 8-K discloses one-time advances of $0.1 million from Hazel Partners Holdings LLC and $0.1 million from VRM MSP Recovery Partners, LLC, conditions on discretionary funding, a historical Aggregate Operational Collection Floor of $7,956,000, a 1-for-7 reverse split effective September 1, 2025, and an OTCQB downgrade to the OTC Pink market effective May 20, 2026.

MSP Recovery, Inc. files a prospectus supplement to register up to 909,982 shares of Class A common stock and up to 755,200,000 warrants, and up to 236,019 shares of Class A common stock issuable upon exercise of warrants, for resale by named selling securityholders. The supplement incorporates a Form 8-K dated May 6, 2026 and reflects a 1-for-7 reverse stock split effective September 1, 2025.

The Form 8-K discloses two one-time short-term financings: a $0.1 million discretionary advance from Hazel Partners Holdings, LLC under the existing working capital facility and a separate $0.1 million one-time advance from VRM MSP Recovery Partners, LLC, each described as standalone accommodations with no commitment for further funding.

MSP Recovery, Inc. amends its prospectus to register 285,715 shares of Class A Common Stock for resale by YA II PN, Ltd. (Yorkville) under the existing Standby Equity Purchase Agreement. The registration supports issuances and resales tied to the Yorkville SEPA and related Convertible Notes, which include conversion mechanics, a 9.99% Ownership Limitation and an Exchange Cap that was lifted effective January 8, 2025. The company notes multiple reductions to the SEPA Floor Price culminating at $0.50, the transfer of listing from Nasdaq to the OTCQB, and a reported closing price of $0.0418 for Common Stock on May 5, 2026.

MSP Recovery, Inc. files a prospectus supplement to register 32,220 shares of Class A Common Stock for resale by selling securityholders, including up to 15,239 shares issuable upon exercise of the CPIA Warrant. The supplement attaches a Form 8-K that discloses two one-time short-term advances: a $0.1 million advance from Hazel Partners to increase discretionary availability under an existing working capital facility, and a $0.1 million advance from VRM MSP Recovery Partners, LLC repayable upon certain financings. The filing notes a 1-for-7 reverse stock split effective September 1, 2025 and market prices quoted as of May 5, 2026. The CPIA Warrant exercise would produce nominal proceeds at its $0.4375 per-share strike.

MSP Recovery, Inc. filed a prospectus supplement registering the resale of up to 56,896 shares of Class A Common Stock by selling securityholders, including shares issuable upon exercise of warrants and shares issued as consideration. The supplement attaches a Form 8-K that discloses two one-time advances of $0.1 million each from Hazel Partners Holdings LLC and VRM MSP Recovery Partners, LLC to support operations and accounts payable. The supplement notes a 1-for-7 reverse stock split effective September 1, 2025, and provides closing market prices as of May 5, 2026. The exercise price for certain warrants is $0.0175 per share, so any proceeds from those exercises would be nominal.

MSP Recovery, Inc. files a prospectus supplement registering 285,715 shares of Class A Common Stock for resale by YA II PN, Ltd. (Yorkville) under a previously disclosed Standby Equity Purchase Agreement (the "Yorkville SEPA"). The supplement incorporates a Form 8-K describing updates to the Yorkville arrangements and short-term lender advances.

The Yorkville SEPA permits the Company to sell shares to Yorkville (up to $250 million in aggregate issuances subject to an Ownership Limitation and other caps), and Yorkville holds convertible notes and advance rights described in the supplement. The prospectus notes the Company will not receive proceeds from Yorkville's resale activity; proceeds to the Company may arise only from shares it elects to sell to Yorkville under the SEPA.

MSP Recovery, Inc. registers 56,896 shares of Class A Common Stock for resale under its S-1 prospectus supplement. The supplement breaks the offering into warrants-related issuances and shares issued for services, and notes a 1-for-7 reverse split effective September 1, 2025.

The filing also attaches a Current Report describing two one-time $0.1 million advances: a Hazel discretionary Operational Collection Floor advance and a VRM advance to support accounts payable; both advances are described as standalone accommodations.

MSP Recovery, Inc. files Prospectus Supplement No. 58 to register the resale of up to 32,220 shares of Class A Common Stock by selling securityholders.

The supplement specifies that up to 15,239 shares are issuable upon exercise of a warrant held by Brickell Key Investments LP (the “CPIA Warrant”) at an exercise price of $0.4375 per share, which would yield only nominal proceeds to the company if exercised. The supplement incorporates a Form 8-K disclosing two one-time advances of $0.1 million each from Hazel Partners Holdings, LLC and VRM MSP Recovery Partners, LLC, and notes a prior 1-for-7 reverse stock split effective September 1, 2025. Closing market quotes on April 17, 2026 are included for common stock and warrants.

MSP Recovery, Inc. filed Prospectus Supplement No. 65 to its S-1 registering up to 909,982 shares of Class A common stock and related resale rights in connection with private and dividend-issued warrants and other legacy instruments. The supplement incorporates an April 16, 2026 Current Report on Form 8-K that discloses two one-time advances of $0.1 million each from Hazel Partners Holdings, LLC and VRM MSP Recovery Partners, LLC to support operating needs and accounts payable. The prospectus notes adjusted warrant economics after the Business Combination, including Public Warrant exercise price of $0.4375 and New Warrant exercise price of $50,312.50, and reports an April 17, 2026 closing common share price of $0.0382. The filing emphasizes that the New Warrants are unlikely to be cash-exercised at current market prices and that the advances are one-time accommodations, with no committed further funding under the working capital facility or from VRM.

MSP Recovery, Inc. amends its May 4, 2024 prospectus to register the resale of up to 32,220 shares of Class A Common Stock. The resale pool includes up to 15,239 shares issuable upon exercise of a warrant (the CPIA Warrant); the exercise price is $0.4375 per share, meaning the company would receive only nominal proceeds if exercised. The supplement attaches a Form 8-K disclosing two one-time advances of $0.1 million each from Hazel Partners and VRM to support operations and accounts payable. The company completed a 1-for-7 reverse split effective September 1, 2025, and share figures in this supplement are adjusted for that split.

MSP Recovery, Inc. files a Prospectus Supplement updating its resale prospectus to register 56,896 shares of Class A Common Stock for resale by selling securityholders. The supplement incorporates an attached Form 8-K that discloses two one-time advances of $0.1 million each from Hazel Partners Holdings, LLC and VRM MSP Recovery Partners, LLC to support operating needs and accounts payable. The filing notes the exercise price of certain warrants is $0.0175 per share and gives April 3, 2026 closing-market quotes; it also states a 1-for-7 reverse stock split became effective September 1, 2025. The advances are described as discrete accommodations and do not create ongoing funding commitments.

MSP Recovery, Inc. files a Prospectus Supplement and attached Form 8-K describing a resale registration and short-term funding arrangements. The prospectus registers up to 909,982 shares of Class A common stock, up to 755,200,000 warrants, and up to 236,019 shares issuable upon warrant exercise. The supplement clarifies that Public Warrants have an adjusted exercise price of $0.4375 and New Warrants carry an exercise price of $50,312.50. The document also discloses two one-time advances: a $0.1 million discretionary advance from Hazel Partners Holdings, LLC to increase the Operational Collection Floor, and a $0.1 million one-time advance of recovery proceeds from VRM MSP Recovery Partners, LLC, each described as standalone accommodations with no commitment for further funding.

MSP Recovery, Inc. filed Prospectus Supplement No. 59 registering 285,715 shares of Class A common stock for potential resale or issuance to YA II PN, Ltd. (Yorkville) under a Standby Equity Purchase Agreement (the “Yorkville SEPA”). The supplement attaches a Form 8-K that discloses recent amendments to the Yorkville facility, multiple Convertible Notes advances and conversion terms, reductions to the SEPA Floor Price down to $0.50, a Nasdaq delisting and transition to OTCQB, and two one-time short-term advances of $0.1 million each from Hazel and VRM to support operations. The Yorkville SEPA provides up to $250 million of issuance capacity subject to an Ownership Limitation (9.99%) and previously an Exchange Cap that was lifted effective January 8, 2025. The company states it will not receive proceeds from Yorkville’s resale activity, though it may elect to sell shares to Yorkville under the SEPA.

MSP Recovery, Inc. registers 285,715 shares of Class A Common Stock for resale by a selling securityholder under its prospectus supplement dated March 23, 2026. The shares were or may be issued to YA II PN, Ltd. ("Yorkville") pursuant to a Standby Equity Purchase Agreement (the "Yorkville SEPA").

The Yorkville SEPA contemplates up to $250 million of Class A Common Stock issuances subject to a 9.99% Ownership Limitation and an Exchange Cap that was effectively lifted January 8, 2025. Yorkville also provided convertible promissory notes with various conversion mechanics and a Floor Price floor that was reduced over time to a $0.50 Floor Price. The Company will not receive proceeds from Yorkville's resale of shares; proceeds from any direct sales to Yorkville under the SEPA would accrue to the Company.

MSP Recovery, Inc. registers the resale by selling securityholders of up to 32,220 shares of its Class A Common Stock, adjusted for a 1-for-7 reverse split. The registration includes up to 15,239 shares issuable upon exercise of a warrant (the CPIA Warrant).

The prospectus supplement notes that should the CPIA Holder exercise the CPIA Warrant, the Company would only receive nominal proceeds because the exercise price is $0.4375 per share. The filing also attaches a Current Report describing two one-time advances totaling $0.2 million from Hazel and VRM to provide near-term liquidity; these advances are standalone accommodations and do not create ongoing funding commitments.